# Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression

> **NCT06765603** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Singapore National Eye Centre** · enrollment: 180 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Atropine 0.025%
- **DEVICE:** Multizonal contact lens
- **DRUG:** Placebo
- **DEVICE:** Single vision Contact lens

## Key facts

- **NCT ID:** NCT06765603
- **Lead sponsor:** Singapore National Eye Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06765603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06765603, "Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06765603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*